hxn-1003 - SERP Analysis

https://academic.oup.com/ecco-jcc/article/19/Supplement_1/i2046/7972069

https://www.biospace.com/press-releases/earendil-labs-announces-worldwide-exclusive-license-agreement-with-sanofi-for-next-generation-bispecific-antibodies-for-autoimmune-and-inflammatory-bowel-diseases

https://synapse.patsnap.com/drug/bcd738b506854c9a801bb558fab13069

https://www.biopharmadive.com/news/sanofi-earendil-immune-drug-deal-tl1a-il23/745616/

https://pryzm.ozmosi.com/product/34402

https://www.prnewswire.com/news-releases/earendil-labs-announces-worldwide-exclusive-license-agreement-with-sanofi-for-next-generation-bispecific-antibodies-for-autoimmune-and-inflammatory-bowel-diseases-302431020.html

https://www.fiercebiotech.com/biotech/sanofi-pens-18b-deal-2-bispecific-antibodies-aimed-autoimmune-immunology

https://www.researchgate.net/publication/388300506_P1114_Engineering_and_Development_of_a_Novel_Bispecific_Antibody_Targeting_IL-23_and_TL1A

https://www.bioworld.com/keywords/59729-hxn-1003

https://pharmashots.com/16209/sanofi-enters-a-1-84b-global-license-agreement-with-earendil-labs-for-hxn-1002-hxn-1003/